IMMUNOCORE HLDGS ADS/1 (6YG) — Net Asset Momentum
IMMUNOCORE HLDGS ADS/1 (6YG) recorded a net asset momentum of 5.6% as of December 2025, with net assets of €381.03 Million EUR. Net Asset Momentum measures the year-over-year percentage change in net assets (total assets minus total liabilities), indicating how rapidly the company is building or eroding its equity base. Check how tangible is IMMUNOCORE HLDGS ADS/1's equity to evaluate the tangible quality of the company's equity base.
YoY Momentum
Current Net Assets
Years of Data
Country
IMMUNOCORE HLDGS ADS/1 Net Asset Momentum (2022–2025)
This chart tracks IMMUNOCORE HLDGS ADS/1's year-over-year net asset growth across 4 annual reporting periods from 2022 to 2025. The most recent momentum reading is +5.6%, with net assets of €381.03 Million EUR as of December 2025. Read total liabilities of IMMUNOCORE HLDGS ADS/1 for a breakdown of total debt and financial obligations.
Annual Net Asset History for IMMUNOCORE HLDGS ADS/1 (2022–2025)
The table below shows the complete annual net asset history for IMMUNOCORE HLDGS ADS/1 from 2022 to 2025, covering 4 yearly periods. Each row includes total assets, total liabilities, net assets, and the year-over-year momentum figure for that period. For live market cap and broader valuation context, see 6YG market cap overview.
| Year | Net Assets (EUR) | Total Assets | Total Liabilities | YoY Momentum |
|---|---|---|---|---|
| 2025 | €381.03 Million | €1.07 Billion | €686.24 Million | ▲ +5.6% |
| 2024 | €360.72 Million | €1.01 Billion | €648.79 Million | ▼ -2.2% |
| 2023 | €368.84 Million | €597.00 Million | €228.16 Million | ▲ +8.8% |
| 2022 | €338.90 Million | €526.76 Million | €187.86 Million | — |